Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A dollar and we all go to Vegas.. your treat is on me :) Lets go SNDY!
Nothing compares to cancer stocks; especially breast cancer. SNDY has the technology to effectively diagnose breast cancer in women and they are creating more advanced medical mammoview diagnostic systems as the increase in breast cancer in women rises with the growing population. VKN* does not compare. SNDY has what it takes to get to the next level. We could even see a run up to $1 dollar. Anything is possible with a real company, with real products and a real vision!
VKN* Ran from around .01 cents to over $1 dollar on the 3D Surgical medical device. Well SNDY HAS A LIFE SAVING MAMMOVIEW Device. Life is precious and Cancer is the #1 killer in the world today apart from heart attacks. SNDY is ready to show its true worth. We should already be trading in Pennies to say the least imo. One big news or one big filing could send us into .05+ cents imo. Heck would not be surprised to see .25 cents to say the least. Last chance for cheapies guys!
WOW. That's Huge $$$$ SNDY going to go parabolic soon imo. Big things in the pipeline for this year and big news due soon :)
SRGE imo is not a fraud. It is up to us as investors to decide if we want to invest or not. It is up to us to believe or not to believe the material we are given. It is a free country :)
SNDY. In 2009 the stock ran from 0030 to 024 cents within days. You know if this company gets CE mark status the stock can actually go as high as .15 to .20 cents who knows if more imo. Remember VKN* ran like around .01 cents to over $1 dollar. Potential here is just huge!
SNDY. In 2009 the stock ran from 0030 to 024 cents within days. You know if this company gets CE mark status the stock can actually go as high as .15 to .20 cents who knows if more imo. Remember VKN* ran like around .01 cents to over $1 dollar. Potential here is just huge!
I would not mention the word fraud for a company. I think that is illegal to say on a board when you do not know the factual evidence provided. It is up to us as investors to believe or not to believe. But no one has the right to say its a fraud i think that is illegal imo. Anyways from what I researched I BELIEVE in the company. Period and Im sure its going to make many wealthy people. Good luck :)
You are absolutely correct. BINGO. Now i just hope everyone is smart enough to know who is right and who is wrong. With precious metal prices on the rise specifically Gold and silver, SRGE should do very well this year and beyond imo. Great opportunity for these cheapies to be worth a fortune very very soon imo.
Yes SNDY .0010 and GDSM .0022 both on target for .01+ imo.
Yes imo it is a very great company to invest in. The price is too cheap. I've been in several other companies that all shot up from similar prices. These types of opportunity are rare and you need to be lucky to be in before the crowd. Imo big opportunity here. Do some DD on this company and I'm sure you will be satisfied imo. Good luck :)
Welcome to the board T rider. Get ready for a great time with SNDY. Big things in the makings about to come out one by one imo. Great Investor Relations team, Great company, great products in a billion dollar market. Extremely undervalued medical/ biotech stock we have here.
YES SRGE HAS A MINE!!!!!!!!!YES SRGE WILL RUN. ALOT OF SMART INVESTORS SLOWLY LOADING UP. THE RUN IS GOING TO SURPRISE MANY IMO. Good luck to all :)
200 boardmarks and rising.
The doctors investment is indeed a very good sign. Looks like something is surely up. We are getting closer and closer to the big payday when we hit .01+ cents.
The CEO himself and I stand firmly with SRGE. Incredible company and incredible CEO very polite and even asked me to call him if I had anymore questions. Very very confident in my investment after speaking with him. This is a GEM.
Looks like insider buying to me. This looks to be start of something big coming. A few of these chances of a lifetime opportunity imo.
199 boardmarks and rising! Up from 195 yesterday night. Lets go SNDY.
News or even an 8k filing itself will send this stock into orbit .02+ imo. Huge potential. The good part is big news is expected to be out anyday now. Most likely news before end of the month imo based on the pattern of when news is normally released by the company.
SNDY (Solos Endoscopy).0010 cents and the most undervalued Biotech health stock perhaps ever imo. On Sept. 17th 2009 news regarding contracts with various Cancer Institutes skyrocketed this stock from .0030 cents to .024 cents. Now with a ton of sales on their latest mammoview breast cancer devices + a number of various things in the pipelines as well as CE mark pending the stock could easily see beyond .02+ cents again shortly. The time to buy SNDY is NOW and reap the profits thereafter imo. Support the women of the world today and help beat the fight against breast cancer. Invest for a good cause and let your investment reward you numerous times in the very near future imo.
Yes spoke to the Company last week. That is why I am soo confident 100%!!!!
SNDY- On Sept. 17th 2009 news regarding contracts with various Cancer Institutes skyrocketed this stock from .0030 cents to .024 cents. Now with a ton of sales on their latest mammoview breast cancer device+ a number of various things in the pipelines as well as CE mark pending the stock could easily see beyond .02+ cents again shortly. The time to buy SNDY is now and reap the profits soon times imo.
SRGE -Great synopsis for others to read upon. Thanks for sharing.
SNDY .0010- Huge volume over 29+ million yesterday. Something is up imo. Extremely undervalued company just getting discovered in a billion dollar breast cancer detection/ medical sector. Could see .01+ cents near term imo.
SNDY .0010- Huge volume over 29+ million yesterday. Something is up imo. Extremely undervalued company just getting discovered in a billion dollar breast cancer detection/ medical sector. Could see .01+ cents near term imo.
SNDY Goes Google. Apple Application is HUGE way to expand further. Very briliant. This company has so much going for it in which the PPS should be much much higher imo. Looks like we will see a huge breakout like last year to .02+ cents soon imo.
Solos Endoscopy Goes Google
Print
Alert
Solos Endoscopy (PC) (USOTC:SNDY)
Historical Stock Chart
3 Months : October 2011 to January 2012
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company is going Google. Solos Endoscopy, by switching to Google Apps, will be able to expand and improve collaboration with its vendors and clients as well as help its employees communicate efficiently. Solos will now have the capability to communicate and access its content from any Internet connected computer or mobile device, helping the Company reduce its IT costs.
In addition to Google Apps, Solos Endoscopy will now use Constant Contact's effective and affordable online marketing tools to win customers and build strong, lasting relationships. These online marketing tools are specially designed to help small businesses and organizations drive participation and strengthen relationships.
As part of its Social Media Campaign, Solos Endoscopy plans on using the following Constant Contact tools:
- Email Marketing for quickly creating professional-looking emails, managing contact lists, measuring campaign results, and reviewing new list members;
- Social Media Marketing for turning fans, friends, and followers into customers. Harnessing digital word of mouth from Facebook, retweeting offers on Twitter, or posting a review on Yelp keeps the conversation going and generates a powerful buzz for Solos Endoscopy;
- Event Marketing for efficiently promoting and managing registrations and RSVPs for meetings, functions, seminars, and events;
- Online Survey for gathering feedback that helps meet Solos customer needs, generate new ideas, and help grow a business or organization.
"We are committed to using the 21st Century tools to effectively market our product line to Hospitals across the Country and around the World," stated Bob Segersten, President of Solos Endoscopy, Inc.
About Constant Contact, Inc.
Constant Contact is revolutionizing the success formula for small organizations through affordable, easy-to-use Engagement Marketing™ tools that help create and grow customer relationships. More than 450,000 small businesses, nonprofits, and associations worldwide rely on Constant Contact to drive ongoing customer dialogs through email marketing, social media marketing, event marketing, and online surveys.
Constant Contact and the Constant Contact Logo are registered trademarks of Constant Contact, Inc. All Constant Contact product names and other brand names mentioned herein are trademarks or registered trademarks of Constant Contact, Inc. All other company and product names may be trademarks or service marks of their respective owners.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
CONTACT: Amanda Segersten rsegersten@solosendoscopy.com
SOURCE Solos Endoscopy, Inc.
SNDY.0010-Remember VKN* ran from 008 to $1+ dollar on their new 3D device for medical use. Well SNDY has a state of the art cost effective breast cancer detection mamogram system in which it is selling like hot cakes. The revenues are going to go through the roof for 2012 as they expect. Watch our PPS head towards multi- pennies imo. Holding tight and also grabbing what I can.
Great post! Person mark for you.
SNDY .0010-The Company has developed products that have enhanced the ability to perform minimally invasive surgical techniques. Products range from complete video systems to specialized hand held instruments. Their specialty is the mammogram Breast Cancer detection system. State of the art system with cost effective prices. Why not invest in a worthy cause and support the women with the fight against breast cancer today?
Nah no SEC investigation. SRGE going to surprise to those who don't believe imo. Looking for my huge payday here. Done my dd and love the stock.
SRGE has a MINE. SRGE will be releasing some more big news shortly imo next month. Holding tight for .0050 or higher!
**SNDY.0010 Doctor's filing uncovered. This stock is ready to go through the roof. Ran to .02+ last year within DAYS! Breast Cancer is a HUGE Billion Dollar market. Invest for a worthy cause with no pump intended. See the filing below for factual evidence of the doctors investment in SNDY!
Here is the filing of the doctor's investment in SNDY-.......
Statement of Beneficial Ownership (SC 13D)
Date : 07/07/2011 @ 11:45AM
Source : Edgar (US Regulatory)
Stock : Solos Endoscopy (PC) (SNDY)
Quote : 0.001 0.0002 (25.00%) @ 5:00PM
- Statement of Beneficial Ownership (SC 13D)
PrintAlert
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __)
TITLE OF CLASS OF SECURITES
Solos Endoscopy
CUSIP NUMBER:
834371403
NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND
COMMUNICATIONS
Richard Tuch, M.D.
1800 Fairburn Avenue, Suite 206
Los Angeles, CA 90025
(310) 474-1960
DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT
June 28, 2011
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), (f) or (g), check the following box.
[ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 (b) for other
parties to whom copies are to be sent.
The remainder of this cover page shall be filled out for a reporting persons
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange
Act of 1934 (Act) or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
1. NAMES OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Richard Tuch, M.D.
------------------------------------------------------------------------------
-------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
------------------------------------------------------------------------------
-------------------------------------------------
3. SEC USE ONLY
------------------------------------------------------------------------------
-------------------------------------------------
4. SOURCE OF FUNDS*
00
------------------------------------------------------------------------------
-------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) [ ]
-------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
California
------------------------------------------------------------------------------
-------------------------------------------------
7. SOLE VOTING POWER
5,500,000
------------------------------------------------------
-------------------------------------
NUMBER OF 8. SHARED VOTING POWER
SHARES BENEFICIALLY -0-
OWNED BY EACH ------------------------------------------------------
-------------------------------------
REPORTING PERSON 9. SOLE DISPOSITIVE POWER
WITH 5,500,000
------------------------------------------------------
-------------------------------------
10. SHARED DISPOSITIVE POWER
-0-
------------------------------------------------------
-------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,500,000
------------------------------------------------------------------------------
-------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [
]
------------------------------------------------------------------------------
-------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.5% of Common Stock
------------------------------------------------------------------------------
-------------------------------------------------
14. TYPE OF REPORTING PERSON*
EP
------------------------------------------------------------------------------
-------------------------------------------------
SCHEDULE 13D
ITEM 1. SECURITY AND ISSUER
Richard Tuch, M.D.
ITEM 2. IDENTITY AND BACKGROUND
(a) Name
Richard Tuch, M.D., A Professional Corporation, Profit Sharing
Plan (401K)
(b) Business Address
1800 Fairburn Ave., Ste. 206
Los Angeles, CA 90025
(c) Present Principal Occupation
Richard Tuch, M.D. is a physician in private practice in Los
Angeles, California and a private investor.
(d) During the last five years, Dr. Tuch has not been convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) During the last five years, Dr. Tuch has not been a party to a
civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which he was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such
laws.
(f) Citizenship
United States of America
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The source of the funds is from Dr. Tuchs Profit Sharing Pension Plan (401K).
No funds were borrowed.
ITEM 4. PURPOSE OF TRANSACTION
Richard Tuch has acquired all of the 5,500,000 shares for investment purposes
and currently has no plans or proposals that relate to or would result in:
(a) The acquisition by any person or additional securities of the
Issuer or the disposition of securities of the Issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Issuer or any of its
subsidiaries;
(c) A sale or transfer of a material amount of assets of Issuer or any
of its subsidiaries;
(d) Any change in the present board of directors or management of
Issuer, including any plans or proposals to change the number or
term of directors or to fill any existing vacancies on the board;
(e) Any material change in the present capitalization or dividend
policy of Issuer;
(f) Any other material change in Issuer business or corporate
structure;
(g) Changes in Issuers charter, bylaws or instruments corresponding
thereto or other actions which may impede the acquisition of
control of Issuer by any person;
(h) Causing a class of securities of Issuer to be delisted from a
national securities exchange or to cease to be authorized to be
quoted in an inter-dealer quotation system of a registered
national securities association;
(i) A class of equity securities of Issuer becoming eligible for
termination of registration pursuant to Section 12(g) (4) of the
Act;
(j) Any action similar to any of those enumerated above.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Aggregate Number and Percentage of Securities
According to the most recently available information, there are
64,957,710 shares of Issuer common stock outstanding. Richard
Tuch is the record owner of 5,500,000 shares of Issuer common
stock and Dr. Tuch beneficially owns 5,500,000 shares of Issuer
common stock or 8.5% of the outstanding shares.
(b) Power to Vote and Dispose
Dr. Tuch has sole power to vote, or to direct the voting of, and
the sole power to dispose or to direct the disposition of the
5,000,000 shares of the Issuer common stock owned directly by
Richard Tuch, M.D., A Professional Corporation Profit Sharing Plan
(401K).
(c) Transactions within the Past 60 Days
The following lots of shares has been purchased in the last 60
days:
DATE #SHARES PURCHASED PURCHASE PRICE/SHARE BROKERAGE
ACCT.
1a.6/30/2011 500,000 .0065 Merril Lynch
1b. 6/21/11 400,000 shares .0085 Charles Schwab
2. 6/19/11 350,000 shares .0135 Merrill Lynch
3. 6/14/11 850,000 shares .0054 Merrill Lynch
------------------------------------------------------------------------------
-------------------------------------------------
3. 6/20/11 50,000 shares .0095 Charles Schwab
4. 6/17/11 49,900 shares .0148 Charles Schwab
5. 6/16/11 30,000 shares .0155 Charles Schwab
35,712 shares .0155 Charles Schwab
100 shares .018 Charles Schwab
34,288 shares .018 Charles Schwab
6. 6/14/11 500,000 shares .0028 Charles Schwab
7. 6/3/11 300,000 shares .0022 Charles Schwab
------------------------------------------------------------------------------
-------------------------------------------------
8. 5/10/11 50,000 shares .004 Charles Schwab
100,000 .0045 Charles Schwab
9. 5/4/11 150,000 .0055 Charles Schwab
100,000 .005 Charles Schwab
------------------------------------------------------------------------------
-------------------------------------------------
TOTAL 3,500,000
(d) Certain Rights of Other Persons
Not applicable.
(e) Not applicable.
ITEM 6. CONTRACT, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Not applicable
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Not applicable
SCHEDULE 13D
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct.
July 7, 2011
------------------------------------
----------------------------
(Date)
Richard Tuch, M.D. A Professional
Corporation Profit Sharing Plan
(401K)
By: /s/ Richard Tuch
------------------------------------
----------------------------
Richard Tuch, President
------------------------------------
----------------------------
Name and Title
SRGE ready to run imo. It is just a matter of time. Its catching the eyes of folks one by one. Look at many other pos with billions in a/s. We have a great Share structure and we have something big here ready to take us to .0050 or even .01+ cents imo.
Nice this is a great piece of DD here for everyone to see the big picture. I think we are on to something. SNDY is set to go places and show its true worth shortly. Last chance to grab cheapies before the surge towards Penny land .01+ imo
Nice. I love mining stocks too. I have made big on CWRN, up big in GDSM and still holding and got few others in mind. I like to stay diversified. SNDY deals in medical sector with medical conditions including detection of breast cancer. A billion dollar market. Extremely undervalued and only .0010 cents right now :)
Yes it sure is. Breast cancer is no joke. No one wants to see their loved ones taken by it. Let us all invest with our heart into SNDY and at the same time God will reward us for doing a good deed. The payoff will be huge imo. I can just feel it. CE mark status alone could bring us to .10 cents possibly imo. So many things going on for the company. Positive profits on sales and so much more.. It is HUGE!
SNDY .0010- Are you serious? A doctor investing HEAVILY must really have some confidence for sure and may know something we don't. I believe the stock could possibly see .05+ to .10 cents by the end of this year. Near term I think we will see .01+ to .02 cents. If we get the CE mark soon this stock can even hit .10 cents in ONE DAY imo. Who knows if higher. Potential is here.
SNDY .0010- You are Correct NO DILUTION confirmed by the company. Over 12 million on the bid looks like insiders to me hence they tried to take it down to close 2 days in a row so they could load up cheapies at .0008 cents but the bulls won and we closed up green at .0010 cents up 25%. Remember big news is expected this month as the company normally issues news every month. We closed green up 25% from previous close at .0008 cents on insane 29+ million in volume. Looking forward to a great week next wek.
SNDY (Solos Endoscopy) Support womens fight against breast cancer and save their lives. Invest in SNDY today and feel good about saving the lives of women who would otherwise suffer from breast cancer. Early detection is easily accomplished with Solos endocopies state of the art cost effective mamogram breast cancer detection equipment. Sales of their devices are set to go through the roof for 2012. Look forward to big news including the CE mark. This is a great lifechanging opportunity that awaits you imo. Load up while you can guys seriously.
SNDY .0010 The winner at PENNY STOCK RUMBLE yesterday on highest % percentage gainer. Almost 30 million in volume and just under $29,000 dollars in money churning. Something is up imo. CE mark and alot of big news down the pipeline expected for this year. Huge potential to .01+ cents here looking back at how it can easily run to .01+ like it did last year to .02+ cents.